Sethi, Sanjay <br/><br/>
Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials.  [electronic resource] 

 -  Therapeutic advances in respiratory disease   
 - 1753466620905278 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1753-4666 
<br/><br/><label>Standard No.: </label>10.1177/1753466620905278  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenal Cortex Hormones--administration & dosage<br/>Adrenergic beta-Agonists--administration & dosage<br/>Aged<br/>Benzamides--administration & dosage<br/>Bronchodilator Agents--administration & dosage<br/>Carbamates--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Forced Expiratory Volume<br/>Humans<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>Muscarinic Antagonists--administration & dosage<br/>Nebulizers and Vaporizers<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Randomized Controlled Trials as Topic<br/>Recovery of Function<br/>Time Factors<br/>Treatment Outcome